OncoMed Pharmaceuticals Inc: cashflow_operating
| Value | {"amount": 144544000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "currency": "USD"} |
|---|---|
| Period | 2013-01-01 – 2013-12-31 |
| Status | superseded |
| Entity | OncoMed Pharmaceuticals Inc |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:24:56.830834+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/edf4daa3-8e05-4d8a-874e-7b1c19c26fbf
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-15-089346 · Open the official SEC filing →Retrieved: 2026-08-19T12:24:56.830834+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001302573/cashflow-operating/2013-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/edf4daa3-8e05-4d8a-874e-7b1c19c26fbf
History
- supersedes {"amount": 144544000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} (evidence 0001193125-14-104564)